To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Jim Momtazee’s Montes Archimedes Acquisition Corp. combines with Roivant Sciences in $7.3b deal
The transaction is expected to deliver up to $611 million of gross proceeds to fund discovery and development programs at Roviant, a biopharmaceutical company.
